GASTRIC AND ESOPHAGEAL CANCER DRUGS MARKET ANALYSIS
Recent Developments
Moreover, mergers and acquisition activities by key players in this region are expected to propel market growth during the forecast period. For instance, in December 2018, GlaxoSmithKline plc announced the acquisition of TESARO Inc, an oncology-focused company based in Massachusetts, U.S. This acquisition is expected to strengthen GSK's pharmaceutical business by accelerating GSK's pipeline and commercial capability in oncology.
In September 2018, Boehringer Ingelheim acquired all shares of ViraTherapeutics, an Austria-based biopharmaceutical company specializing in the development of oncolytic viral therapies. The total transaction value for this acquisition was US$ 240.52 million. This acquisition strengthened Boehringer Ingelheim's commitment to research and development for viral-based immuno-oncology treatment.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
